InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,467.10
(
-0.04%
)
US TECH 100
19,182.00
(
0.04%
)
Dow Jones
39,145.18
(
0.08%
)
Brent Oil
84.39
(
0.24%
)
Bitcoin
60,948.20
(
-1.40%
)
Post# of 104482
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

chessmite

Send PM Follow Ignore
Followers 33
Posts 3334
Boards Moderated 1
Alias Born 05/26/2010

chessmite

Re: None

Monday, 01/25/2016 7:49:52 AM

Monday, January 25, 2016 7:49:52 AM

Post# of 104482
Establishment of Nitto BioPharma, Inc.


Nitto Denko Corporation (Headquarters: Osaka, Japan; President, CEO & COO: Hideo Takasaki; “Nitto”, hereafter) established a new company, Nitto BioPharma, Inc., with a focus on pharmaceutical development. Nitto has been conducting their first anti-liver fibrosis drug program (ND-L02-s0201), which is now in clinical trials in the US, Europe and Japan, and has several other pipelines of intractable diseases in the discovery stage.


Along with the establishment of the new company, Nitto plans to set up a new facility mid-2016 in the center of the Life Sciences hub in San Diego, California,
http://www.nitto.com/press/2016/0125_01.jsp



Quantum Dots are Building Blocks for the Future
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up